Home › Funds › Citigroup Inc › DYN
Citigroup Inc position in DYN
DYNE THERAPEUTICS INC · Health Care
Latest position (Q2 2026)187.91K sh
Reported value held$4.17M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 3.79K | $62.00K | New |
| Q4 2021 | 13.92K | $165.00K | Add |
| Q1 2022 | 7.43K | $72.00K | Reduce |
| Q2 2022 | 402.66K | $2.77M | Add |
| Q3 2022 | 126.58K | $1.61M | Reduce |
| Q4 2022 | 10.17K | $117.86K | Reduce |
| Q1 2023 | 4.45K | $51.21K | Reduce |
| Q2 2023 | 50.39K | $566.85K | Add |
| Q3 2023 | 61.90K | $554.58K | Add |
| Q4 2023 | 71.60K | $952.33K | Add |
| Q1 2024 | 300.13K | $8.52M | Add |
| Q2 2024 | 36.71K | $1.30M | Reduce |
| Q3 2024 | 64.44K | $2.31M | Add |
| Q4 2024 | 142.92K | $3.37M | Add |
| Q1 2025 | 194.96K | $2.04M | Add |
| Q2 2025 | 61.53K | $585.74K | Reduce |
| Q3 2025 | 33.38K | $422.32K | Reduce |
| Q4 2025 | 36.66K | $717.01K | Add |
| Q1 2026 | 37.80K | $685.26K | Add |
| Q2 2026 | 187.91K | $4.17M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DYN
- BlackRock Inc 12.40M sh · $275.50M · Q2 2026
- Fidelity Management & Research (FMR) 11.21M sh · $248.91M · Q2 2026
- Janus Henderson Group 13.65M sh · $247.43M · Q1 2026
- Vanguard Group 11.22M sh · $219.38M · Q4 2025
- Geode Capital Management 3.74M sh · $83.16M · Q2 2026
- JPMorgan Chase & Co 3.15M sh · $67.15M · Q2 2026
- Bank of America Corp 2.23M sh · $49.60M · Q2 2026
- Goldman Sachs Group 2.16M sh · $47.91M · Q2 2026
- Franklin Resources 2.03M sh · $45.10M · Q2 2026
- Marshall Wace 1.49M sh · $33.07M · Q2 2026
- Northern Trust Corp 1.28M sh · $28.39M · Q2 2026
- Charles Schwab Investment Management 1.20M sh · $26.70M · Q2 2026